Skip to content
Main Menu
  • Excelsior
    • About Excelsior Medical
    • Enterprise Spirit
    • Development Strategy
    • Related Company
    • Overseas Business
    • Company History
  • Product Description
    • Hemodialysis / Plasma Exchange
    • Blood Bag
    • Artificial Stoma
    • Health Appliances
  • ESG
  • Investors
  • Enterprise Recruitment
  • Contact Us

Monthly Sales-2025.07

 

Item Net Revenue
2025.07 713,083
2024.07 648,950
MoM Change 64,133
MoM Change (%) 9.88
2025 1-7 5,027,368
2024 1-7 4,850,635
YoY Change 176,733
YoY Change (%) 3.64
Note

 

PrevPREVIOUSThe Board of Directors approved Q2 2025 consolidated financial statements.
NEXTAnnouncement of the Board of Directors on election of Chairperson on behalf of major subsidiary, Excelsior Asset Management Co., Ltd.Next

Investors

Material Information
Board of Directors
Corporate Governance
Organization
Major Internal Policies
Corporate Governance
Committee
Audit Committee
Remuneration Committee
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders' Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investors
Main Menu
  • Excelsior
    • About Excelsior Medical
    • Enterprise Spirit
    • Development Strategy
    • Related Company
    • Overseas Business
    • Company History
  • Product Description
    • Hemodialysis / Plasma Exchange
    • Blood Bag
    • Artificial Stoma
    • Health Appliances
  • ESG
  • Investors
  • Enterprise Recruitment
  • Contact Us
  • 17F., No. 880, Zhongzheng Rd., Zhonghe Dist., New Taipei City, Taiwan
  • +886-2-2225-1888
[raiseup_copyright]